Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Harvard Bioscience, Inc. (HBIO : NSDQ)

• Company Description    HARVARD BIOSCIENCE develops, manufactures and markets tools used in drug discovery research at pharmaceutical and biotechnology companies, universities and government laboratories. Number of Employees: 355

• Price / Volume Information    Yesterday's Closing Price: $0.41 Daily Weekly Monthly 20 Day Moving Average: 593,342 shares Shares Outstanding: 44.53 (millions) Market Capitalization: $18.26 (millions) Beta: 1.52 52 Week High: $2.82 52 Week Low: $0.28 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -10.42% -11.47% 12 Week -17.98% -22.42% Year To Date -80.57% -83.03%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 84 OCTOBER HILL RD - HOLLISTON,MA 01746 USA ph: 508-893-8999 fax: 508-429-5732 investors@harvardbioscience.com http://www.harvardbioscience.com

• General Corporate Information    Officers James Green - Chief Executive Officer and Director Jennifer Cote - Chief Financial Officer Katherine A. Eade - Director Alan Edrick - Director Thomas W. Loewald - Director Peer Information Harvard Bioscience, Inc. (DNEX) Harvard Bioscience, Inc. (T.PUR) Harvard Bioscience, Inc. (CALP.) Harvard Bioscience, Inc. (CCSI.) Harvard Bioscience, Inc. (NEWP.) Harvard Bioscience, Inc. (PBSC) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: INSTRU-SCIENTFC Sector: Computer and Technology CUSIP: 416906105 SIC: 3826 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/06/25 Share - Related Items Shares Outstanding: 44.53 Most Recent Split Date: (:1) Beta: 1.52 Market Capitalization: $18.26 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/06/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 1.15 Price/Cash Flow: 4.06 Price / Sales: 0.21 EPS Growth vs. Year Ago Period: 33.33% vs. Previous Quarter: 0.00% Sales Growth vs. Year Ago Period: -11.46% vs. Previous Quarter: -6.08% ROE 09/30/25 - - 06/30/25 - -5.64 03/31/25 - -4.96 ROA 09/30/25 - - 06/30/25 - -2.15 03/31/25 - -2.24 Current Ratio 09/30/25 - - 06/30/25 - 0.81 03/31/25 - 0.81 Quick Ratio 09/30/25 - - 06/30/25 - 0.41 03/31/25 - 0.40 Operating Margin 09/30/25 - - 06/30/25 - -2.53 03/31/25 - -2.86 Net Margin 09/30/25 - - 06/30/25 - -64.68 03/31/25 - -63.51 Pre-Tax Margin 09/30/25 - - 06/30/25 - -64.17 03/31/25 - -63.43 Book Value 09/30/25 - - 06/30/25 - 0.36 03/31/25 - 0.34 Inventory Turnover 09/30/25 - - 06/30/25 - 1.62 03/31/25 - 1.61 Debt-to-Equity 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00 Debt-to-Capital 09/30/25 - - 06/30/25 - 0.00 03/31/25 - 0.00

Powered by Zacks Investment Research ©